Mayne Pharma is headquartered in Salisbury South, Australia.
Mayne Pharma disclosed revenue of 388M AUD for 2024 and 182M AUD for 2023.
Mayne Pharma is a life science company.
1528 Main North Road,
Salisbury South,
5106
Australia,
61 8 8209 2666
www.maynepharma.com
Mayne Pharma is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services. Mayne Pharma is based in Salisbury South, Australia.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 4 | - | - | - | - | - | 4 |
| vol | $120M | $120M | ||||||
| Sell (0.2/yr) | # | 1 | - | 1 | - | - | - | 2 |
| vol | $475M | $475M | ||||||
| 6 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
